Evidence map›Paper›PMID 42518000›Full record

ArticleJournal of bioenergetics and biomembranes2026

The fullerenol C

Ashura Israfilova, Albina Dzhafarova, Vagab Abdulaev, Aina Adieva, Maria Markova, Kamila Sfieva, Anna Titova, Zhanna Lyutova, Alina Borisenkova

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ashura IsrafilovaCaspian Institute of Biological Resources, Dagestan Federal Research Center, Russian Academy of Sciences, Makhachkala, Russia.ORCID http://orcid.org/0009-0001-6318-595X
Albina DzhafarovaDagestan State University, Makhachkala, Russia.ORCID http://orcid.org/0000-0001-7744-859X
Vagab AbdulaevDagestan State University, Makhachkala, Russia.ORCID http://orcid.org/0000-0002-3551-1746
Aina AdievaCaspian Institute of Biological Resources, Dagestan Federal Research Center, Russian Academy of Sciences, Makhachkala, Russia.ORCID http://orcid.org/0000-0001-8868-4782
Maria MarkovaRadiation Technology Department, St. Petersburg State Institute of Technology (Technical University), St. Petersburg, 190013, Russia.ORCID http://orcid.org/0009-0006-4844-2504
Kamila SfievaCaspian Institute of Biological Resources, Dagestan Federal Research Center, Russian Academy of Sciences, Makhachkala, Russia.ORCID http://orcid.org/0009-0009-3012-1034
Anna TitovaRadiation Technology Department, St. Petersburg State Institute of Technology (Technical University), St. Petersburg, 190013, Russia.ORCID http://orcid.org/0000-0002-9151-7739
Zhanna LyutovaRadiation Technology Department, St. Petersburg State Institute of Technology (Technical University), St. Petersburg, 190013, Russia.ORCID http://orcid.org/0000-0001-6925-2802
Alina BorisenkovaRadiation Technology Department, St. Petersburg State Institute of Technology (Technical University), St. Petersburg, 190013, Russia. borisenkova_aa@pnpi.nrcki.ru.ORCID http://orcid.org/0000-0002-7618-5617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fullerenols, which possess antioxidants, anti-inflammatory, and neuroprotective properties, can affect mitochondria. The effect of fullerenol C₆₀(OH)₃₆ on the structural-dynamic and functional parameters of mitochondria, both isolated in vitro and in vivo in Wistar rats, was studied. It was found that fullerenol at a dose of 10 mg/kg reduced bioenergetic parameters of both glutamate-dependent and succinate-dependent intracellular respiration in vivo. In the in vitro model system, fullerenol at a dose of 0.2 mg/ml significantly decreased the oxygen consumption rates in all metabolic states, leading to a reduction in the Lardy and Chance respiratory control ratios and the P/O ratio. Conversely, at a dose of 0.1 µg/ml, fullerenols significantly increased these respiratory parameters. Fullerenols, both in vivo and in vitro, increased the viscosity of annular and total mitochondrial membrane lipids. They did not affect the polarity of total lipids but decreased the polarity of annular lipids. Fullerenols at high doses induced significant conformational changes in membrane proteins, increasing their immersion into the lipid matrix. Our results demonstrate that fullerenols modulate mitochondrial bioenergetics and membrane structural dynamics in a dose-dependent manner, which may have implications for understanding both the cytoprotective and potentially cytotoxic effects of these nanoparticles.

Indexed as

FullerenesMitochondriaMitochondria, LiverMitochondrial MembranesAnimalsEnergy MetabolismMaleOxygen ConsumptionRatsRats, WistarFullerenesfullerenolFullerenolsMitochondriaMitochondrial dysfunctionMitochondrial permeability transition pore (mPTP)Oxidative stress

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.